Boston Scientific Corporation (BSX) NYSE
69.13
+0.575(+0.84%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
69.13
+0.575(+0.84%)
Currency In USD
| Market Cap | 141.16B |
| Enterprise Value | 151.53B |
| P/E Ratio | 35.47 |
| PEG Ratio | 9.58 |
| Price/Sales Ratio | 5.11 |
| Price/Book Ratio | 4.23 |
| Enterprise/Revenue | 5.63 |
| Enterprise/EBITDA | 23.01 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0.14 |
| Operating Margin | 0.2 |
| Return On Assets | 0.07 |
| Return On Equity | 0.13 |
| Revenue | 20.07B |
| Revenue/Share | 13.54 |
| Gross Profit | 13.85B |
| EBITDA | 3.73B |
| Net Income | 2.89B |
| Diluted EPS | 1.94 |
| Total Cash | 2.05B |
| Total Cash/Share | 1.38 |
| Total Debt | 12.42B |
| Total Debt/Equity | 0.51 |
| Current Ratio | 1.62 |
| Book Value Per Share | 16.51 |
| 52-Week Change | -27.51 |
| 52-Week High | 109.5 |
| 52-Week Low | 67.56 |
| Moving Average 50 Days | 83.56 |
| Moving Average 200 Days | 96.78 |
| Average Volume | 14.5M |
| Shares Outstanding | 1.48B |
| % Held by Institutions | 92.04 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 2:1 |
| Last Split Date | November 06, 2003 |